Cytodyn Inc (CYDY)

[fred198484]

You folks really need to look at reality. CYDY needs money to complete their trials but their current financial structure is completely untenable. They can't sell new shares with 55 million warrants out there unless the new shares are sold at such a low price that the warrants will never be converted to equity. At least they cannot sell shares in any conventional fashion. It is unlikely they can raise $100 million under any circumstance, but they may get enough through unconventional means to keep going for a while longer.

Second, what is the point of doing a P III trial just like the Ibalizumab one when Ibalizumab is already a superior drug to PRO 140 and will have a huge head start in the market over it? CYDY should be shooting for the home run on monotherapy as this is its best chance of making it. If a P III monotherapy trial was successful, the company could become quite valuable. It would take two phase III tests to get it approved and those tests would be large tests costing a lot of money. So, if you believed PRO 140 would have 2 successful P III monotherapy tests, which I think is possible, you should not invest in it until they have acquired all the capital needed to pull those tests off. If you buy before that, you are certain to be heavily diluted. Current shareholders are going to be diluted into the dust. The company may survive and the drug may make it to the market in 2020 or so, but current shareholders will not be enriched in the process.